Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-13,037
Closed -$1.2M 702
2024
Q1
$1.2M Buy
+13,037
New +$1.22M 0.01% 612
2021
Q3
Sell
-16,000
Closed -$3.92M 613
2021
Q2
$3.92M Buy
16,000
+12,473
+354% +$3.27M 0.03% 303
2021
Q1
$934K Buy
+3,527
New +$995K 0.01% 626

Other funds holding AMED

CIBC World Markets's AMED Position: Q2 2024 in Review

CIBC World Markets sold out of Amedisys (AMED) in Q2 2024, closing a stake of 13,037 shares — an estimated $1.2M sold.

CIBC World Markets first reported a position in AMED in Q1 2021 and held it in 3 quarters. The position peaked at $3.92M in Q2 2021. 288 funds tracked by Wall St. Rank hold AMED as of Q2 2024.

  • CIBC World Markets reported no remaining Amedisys position as of Q2 2024 after selling out during the quarter.
  • CIBC World Markets sold 13,037 Amedisys shares in Q2 2024, an estimated $1.2M.
  • CIBC World Markets first reported a position in Amedisys in Q1 2021 and held it in 3 quarters.
  • CIBC World Markets's Amedisys position peaked at $3.92M in Q2 2021.
  • 288 funds tracked by Wall St. Rank held Amedisys as of Q2 2024.

Based on CIBC World Markets's 13F filing for Q2 2024, filed 12 Aug 2024.